{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 0.7142851, "regularMarketPrice": 1.41, "exchange": "NCM", "shortName": "Cadrenal Therapeutics, Inc.", "longName": "Cadrenal Therapeutics, Inc.", "messageBoardId": "finmb_1793167154", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1674225000000, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "preMarketChange": 0.19000006, "preMarketChangePercent": 13.475182, "preMarketTime": 1684227722, "preMarketPrice": 1.6, "regularMarketChange": 0.00999999, "regularMarketTime": 1684180804, "regularMarketDayHigh": 1.4793, "regularMarketDayRange": "1.39 - 1.4793", "regularMarketDayLow": 1.39, "regularMarketVolume": 14627, "regularMarketPreviousClose": 1.4, "bid": 0.0, "ask": 0.0, "bidSize": 22, "askSize": 13, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 1.43, "averageDailyVolume3Month": 47548, "averageDailyVolume10Day": 26650, "fiftyTwoWeekLowChange": 0.20999992, "fiftyTwoWeekLowChangePercent": 0.17499992, "fiftyTwoWeekRange": "1.2 - 6.75", "fiftyTwoWeekHighChange": -5.34, "fiftyTwoWeekHighChangePercent": -0.7911111, "fiftyTwoWeekLow": 1.2, "fiftyTwoWeekHigh": 6.75, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "sharesOutstanding": 11634600, "bookValue": -0.677, "fiftyDayAverage": 1.45066, "fiftyDayAverageChange": -0.040660024, "fiftyDayAverageChangePercent": -0.028028637, "twoHundredDayAverage": 1.8083, "twoHundredDayAverageChange": -0.39830005, "twoHundredDayAverageChangePercent": -0.22026215, "marketCap": 17224982, "priceToBook": -2.082718, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-01-20", "displayName": "Cadrenal Therapeutics", "symbol": "CVKD"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "822 A1A North", "address2": "Suite 306", "city": "Ponte Vedra", "state": "FL", "zip": "32082", "country": "United States", "phone": "904 300 0701", "website": "https://www.cadrenal.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Quang X. Pham", "age": 57, "title": "Chairman & CEO", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 822173, "fmt": "822.17k", "longFmt": "822,173"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Matthew K. Szot CPA, CPA", "age": 48, "title": "Co-Founder & CFO", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": {"raw": 359605, "fmt": "359.61k", "longFmt": "359,605"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Douglas W. Losordo FACC, FAHA, M.D.", "age": 64, "title": "Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 23360, "fmt": "23.36k", "longFmt": "23,360"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}